Inhibidor JNK IX 312917-14-9
Descripción del producto
.cp_wz tabla {borde superior: 1px sólido #ccc; borde izquierdo: 1px sólido #ccc; } .cp_wz table td {borde derecho: 1px sólido #ccc; borde inferior: 1px sólido #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; relleno: 5px 0px 0px 5px;} \ n Peso molecular: \ n 332.42 El inhibidor de JNK IX es un inhibidor de JNK selectivo y potente con pIC50 de 6.5 y 6.7 para JNK2 y JNK3, respectivamente. \ n Actividad biológica
Protocolo (solo como referencia) Ensayo de quinasa: [1]
Conversión de diferentes modelos de animales basados en BSA (valor basado en datos del Borrador de Directrices de la FDA)
Por ejemplo, para modificar la dosis de resveratrol utilizada para un ratón (22,4 mg / kg) a una dosis basada en el BSA para una rata, multiplique 22,4 mg / kg por el factor Km para un ratón y luego divida por el factor Km para una rata. Este cálculo da como resultado una dosis equivalente para ratas de resveratrol de 11,2 mg / kg.
Información química
Calculadora de molaridad Calculadora de dilución Calculadora de peso molecular
Description | JNK inhibitor IX is a selective and potent JNK inhibitor with pIC50 of 6.5 and 6.7 for JNK2 and JNK3, respectively. | |||||
---|---|---|---|---|---|---|
Targets | JNK3 [1] | JNK2 [1] | ||||
IC50 | 6.7(pIC50) | 6.5(pIC50) | ||||
In vitro | JNK inhibitor IX significantly reduces caspase-3 activity by the inhibition of JNK activity in human dermal fibroblasts. JNK inhibition by JNK inhibitor IX significantly increases apoptotic death in response to imatinib mesylate (IM) by preventing c-ABL complete de-phosphorylation at Ser residues. | |||||
In vivo |
|
|||||
Features |
|
JNK3 kinase inhibitory activity | JNK3 kinase inhibitory activity is determined using a fluorescence anisotropy kinase binding assay. The kinase, a fluorescently labelled inhibitor and a variable concentration of test compound are incubated together to reach thermodynamic equilibrium under conditions such that in the absence of test compound the fluorescent inhibitor is significantly (>50%) enzyme bound and in the presence of a sufficient concentration of a potent inhibitor the anisotropy of the unbound fluorescent ligand is measurably different from the bound value. Truncated human JNK3 is expressed in baculovirus as a N-terminal His (6)-tagged fusion protein. This enzyme (JNK3) is activated in 50 mM Tris/HCl, pH 7.5, 0.1 mM EGTA, 0.1% β-mercaptoethanol, 0.1 mM sodium vanadate, 10 mM magnesium acetate, 0.1 mM ATP with 100 nM active MKK4 and MKK7β at 30°C for 30 min. Following activation, the JNK3 is purified by Ni-NTA agarose chromatography. The JNK3 is then dialyzed into storage buffer (50 mM Tris/HCl, pH 7.5, 270 mM Sucrose, 150 mM NaCl, 0.1 mM EGTA, 0.1% β-mercaptoethanol, 0.03% Brij-35, 1 mM benzamidine and 0.2 mM PMSF), snap frozen in liquid nitrogen and stored at −70°C. Inhibitor binding to JNK3 is assessed by a fluorescence anisotropy competitive binding assay. All components are dissolved in buffer of composition 50 mM Hepes, pH 7.5, 1 mM CHAPS, 1 mM DTT, 10 mM MgCl2 with final concentrations of 10 nM JNK3 and 2 nM of a fluorescently labelled inhibitor. This reaction mixture is added to wells containing various concentrations of test compound (0.28 nM-16.6 μM final) or DMSO vehicle ( |
---|
Species | Baboon | Dog | Monkey | Rabbit | Guinea pig | Rat | Hamster | Mouse |
Weight (kg) | 12 | 10 | 3 | 1.8 | 0.4 | 0.15 | 0.08 | 0.02 |
Body Surface Area (m2) | 0.6 | 0.5 | 0.24 | 0.15 | 0.05 | 0.025 | 0.02 | 0.007 |
Km factor | 20 | 20 | 12 | 12 | 8 | 6 | 5 | 3 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × | mouse Km(3) | = 11.2 mg/kg |
rat Km(6) |
Molecular Weight (MW) | 332.42 |
---|---|
Formula |
C20 H16 N2 O S |
CAS No. | 312917-14-9 |
Storage | 3 years -20℃Powder |
---|---|
6 months-80℃in solvent (DMSO, water, etc.) | |
Synonyms | TCS JNK 5a |
Solubility (25°C) * | In vitro | DMSO | 20 mg/mL (60.16 mM) |
---|---|---|---|
Water | <1 mg/mL ( | ||
Ethanol | <1 mg/mL ( | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Chemical Name | 1-Naphthalenecarboxamide, N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thien-2-yl)- |
---|
Grupos de Producto : MAPK > Inhibidor de JNK
Otros productos
Productos hot
Astragalósido AClortetraciclina HCl 64-72-2Paclitaxel 33069-62-4Acetato de dexametasona 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatrán (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropil (XL335) 629664-81-9BMS-378806 357263-13-9